Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.

Colozza, M; Gori, S; Mosconi, A M; Anastasi, P; de Angelis, V; Giansanti, M; Mercati, U; Aristei, C; Latini, P; Tonato, M

Colozza, M; Gori, S; Mosconi, A M; Anastasi, P; de Angelis, V; Giansanti, M; Mercati, U; Aristei, C; Latini, P; Tonato, M.

Affiliation

Colozza M; Medical Oncology Division, Policlinico Hospital, Perugia, Italy.

Am J Clin Oncol ; 19(1): 10-7, 1996 Feb.

Article in En | MEDLINE | ID: mdl-8554028

Subject(s)

Adenocarcinoma/drug therapy; Adenocarcinoma/secondary; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adenocarcinoma/radiotherapy; Adenocarcinoma/surgery; Adult; Aged; Breast Neoplasms/radiotherapy; Breast Neoplasms/surgery; Chemotherapy, Adjuvant; Cisplatin/administration & dosage; Combined Modality Therapy; Cyclophosphamide/administration & dosage; Disease-Free Survival; Doxorubicin/administration & dosage; Female; Fluorouracil/administration & dosage; Humans; Mastectomy, Radical; Methotrexate/administration & dosage; Middle Aged; Neoplasm Staging; Radiotherapy Dosage

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 1996 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links